![Inventiva](/common/images/company/EU_IVA.png)
Inventiva publie ses informations financières préliminaires du premier semestre 2024¹ Trésorerie et équivalents de trésorerie à 10,1 millions d’euros au 30 juin 2024, contre 26,9 millions d’euros...
Inventiva Reports Preliminary 2024 First-Half Financial Information¹ Cash and cash equivalents at €10.1 million as of June 30, 2024, compared to cash and cash equivalents at €26.9 million, €0.012...
Cash and cash equivalents at €10.1 million as of June 30, 2024, compared to cash and cash equivalents at €26.9 million, €0.012 million of short-term deposits and €9.03 million of long-term...
Inventiva obtient un nouveau brevet au Japon, élargissant la protection de la propriété intellectuelle de lanifibranor ► L'Office des brevets japonais a accordé la demande de brevet d'Inventiva...
Inventiva secures a new patent in Japan, expanding the IP protection of its lead product candidate lanifibranor Japanese Patent Office approved Inventiva’s patent application relating to the use...
Japanese Patent Office approved Inventiva’s patent application relating to the use of lanifibranor for the treatment of cirrhosis.1This patent strengthens Inventiva’s intellectual property with...
Bilan semestriel du contrat de liquidité de la société Inventiva conclu avec Kepler Cheuvreux Daix (France), Long Island City (New York, Etats-Unis), le 19 juillet 2024 – Inventiva (Euronext...
Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux Daix (France), Long Island City (New York, United States), July 19, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA...
Inventiva announces a €20.1 million issuance of royalty certificates Royalty certificates subscribed by Samsara BioCapital and existing shareholders (BVF Partners, NEA, Sofinnova and...
Royalty certificates subscribed by Samsara BioCapital and existing shareholders (BVF Partners, NEA, Sofinnova and Yiheng).Royalty of 3% on future net sales of lanifibranor in the United States of...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.03 | -1.42857142857 | 2.1 | 2.19 | 2.04 | 17643 | 2.11176365 | DE |
4 | -0.28 | -11.914893617 | 2.35 | 2.56 | 2.04 | 30084 | 2.25666367 | DE |
12 | -1.47 | -41.5254237288 | 3.54 | 3.555 | 2.04 | 38335 | 2.6566868 | DE |
26 | -1.37 | -39.8255813953 | 3.44 | 4.3 | 2.04 | 51422 | 3.0977681 | DE |
52 | -1.49 | -41.8539325843 | 3.56 | 4.55 | 2.04 | 54328 | 3.43008352 | DE |
156 | -7.33 | -77.9787234043 | 9.4 | 13.18 | 1.88 | 52822 | 4.54679528 | DE |
260 | 0.31 | 17.6136363636 | 1.76 | 16.3 | 1.54 | 65838 | 6.93944996 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.